Cardiac Autonomic Neuropathy: A Progressive Consequence of Chronic Low-Grade Inflammation in Type 2 Diabetes and Related Metabolic Disorders
Open Access
- 27 November 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (23), 9005
- https://doi.org/10.3390/ijms21239005
Abstract
Cardiac autonomic neuropathy (CAN) is one of the earliest complications of type 2 diabetes (T2D), presenting a silent cause of cardiovascular morbidity and mortality. Recent research relates the pathogenesis of cardiovascular disease in T2D to an ensuing chronic, low-grade proinflammatory and pro-oxidative environment, being the hallmark of the metabolic syndrome. Metabolic inflammation emerges as adipose tissue inflammatory changes extending systemically, on the advent of hyperglycemia, to reach central regions of the brain. In light of changes in glucose and insulin homeostasis, dysbiosis or alteration of the gut microbiome (GM) emerges, further contributing to inflammatory processes through increased gut and blood–brain barrier permeability. Interestingly, studies reveal that the determinants of oxidative stress and inflammation progression exist at the crossroad of CAN manifestations, dictating their evolution along the natural course of T2D development. Indeed, sympathetic and parasympathetic deterioration was shown to correlate with markers of adipose, vascular, and systemic inflammation. Additionally, evidence points out that dysbiosis could promote a sympatho-excitatory state through differentially affecting the secretion of hormones and neuromodulators, such as norepinephrine, serotonin, and γ-aminobutyric acid, and acting along the renin–angiotensin–aldosterone axis. Emerging neuronal inflammation and concomitant autophagic defects in brainstem nuclei were described as possible underlying mechanisms of CAN in experimental models of metabolic syndrome and T2D. Drugs with anti-inflammatory characteristics provide potential avenues for targeting pathways involved in CAN initiation and progression. The aim of this review is to delineate the etiology of CAN in the context of a metabolic disorder characterized by elevated oxidative and inflammatory load.This publication has 138 references indexed in Scilit:
- Increased Th1 and suppressed Th2 serum cytokine levels in subjects with diabetic coronary artery diseaseCardiovascular Diabetology, 2014
- Oxidative Stress as an Underlying Contributor in the Development of Chronic Complications in Diabetes MellitusInternational Journal of Molecular Sciences, 2013
- High Fat Diet-Induced Gut Microbiota Exacerbates Inflammation and Obesity in Mice via the TLR4 Signaling PathwayPLOS ONE, 2012
- Sympathetic overactivity precedes metabolic dysfunction in a fructose model of glucose intolerance in miceAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2012
- Linking mitochondrial bioenergetics to insulin resistance via redox biologyTrends in Endocrinology & Metabolism, 2012
- Sympathetic nervous dysregulation in the absence of systolic left ventricular dysfunction in a rat model of insulin resistance with hyperglycemiaCardiovascular Diabetology, 2011
- Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic DiseaseCell, 2010
- PPAR γ is highly expressed in F4/80hi adipose tissue macrophages and dampens adipose-tissue inflammationCellular Immunology, 2009
- Emerging role of adipose tissue hypoxia in obesity and insulin resistanceInternational Journal of Obesity, 2008
- Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic PatientsDiabetes, 2008